The story of Viagra, initially marketed by copyright, presents a fascinating case study for investors considering the healthcare landscape . Although its groundbreaking success and creation of billions in sales, the patent expiration has opened the way for alternative medications, significantly eroding profit opportunities. This shift raises questi